190 related articles for article (PubMed ID: 27425854)
1. Genomic characterization of recurrent high-grade astroblastoma.
Bale TA; Abedalthagafi M; Bi WL; Kang YJ; Merrill P; Dunn IF; Dubuc A; Charbonneau SK; Brown L; Ligon AH; Ramkissoon SH; Ligon KL
Cancer Genet; 2016; 209(7-8):321-30. PubMed ID: 27425854
[TBL] [Abstract][Full Text] [Related]
2. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
[TBL] [Abstract][Full Text] [Related]
3. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
Boisseau W; Euskirchen P; Mokhtari K; Dehais C; Touat M; Hoang-Xuan K; Sanson M; Capelle L; Nouet A; Karachi C; Bielle F; Guégan J; Marie Y; Martin-Duverneuil N; Taillandier L; Rousseau A; Delattre JY; Idbaih A
Oncologist; 2019 Dec; 24(12):1584-1592. PubMed ID: 31346129
[TBL] [Abstract][Full Text] [Related]
4. Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization.
Brat DJ; Hirose Y; Cohen KJ; Feuerstein BG; Burger PC
Brain Pathol; 2000 Jul; 10(3):342-52. PubMed ID: 10885653
[TBL] [Abstract][Full Text] [Related]
5. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
[TBL] [Abstract][Full Text] [Related]
6. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.
Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA
Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma.
Diamandis P; Ferrer-Luna R; Huang RY; Folkerth RD; Ligon AH; Wen PY; Beroukhim R; Ligon KL; Ramkissoon SH
Diagn Pathol; 2016 Jan; 11():13. PubMed ID: 26817999
[TBL] [Abstract][Full Text] [Related]
9. Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.
Ramkissoon SH; Bandopadhayay P; Hwang J; Ramkissoon LA; Greenwald NF; Schumacher SE; O'Rourke R; Pinches N; Ho P; Malkin H; Sinai C; Filbin M; Plant A; Bi WL; Chang MS; Yang E; Wright KD; Manley PE; Ducar M; Alexandrescu S; Lidov H; Delalle I; Goumnerova LC; Church AJ; Janeway KA; Harris MH; MacConaill LE; Folkerth RD; Lindeman NI; Stiles CD; Kieran MW; Ligon AH; Santagata S; Dubuc AM; Chi SN; Beroukhim R; Ligon KL
Neuro Oncol; 2017 Jul; 19(7):986-996. PubMed ID: 28104717
[TBL] [Abstract][Full Text] [Related]
10. Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement.
Hirose T; Nobusawa S; Sugiyama K; Amatya VJ; Fujimoto N; Sasaki A; Mikami Y; Kakita A; Tanaka S; Yokoo H
Brain Pathol; 2018 Sep; 28(5):684-694. PubMed ID: 28990708
[TBL] [Abstract][Full Text] [Related]
11. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.
Lehman NL
J Neurooncol; 2023 Feb; 161(3):425-439. PubMed ID: 36604386
[TBL] [Abstract][Full Text] [Related]
12. Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis.
Heiland DH; Staszewski O; Hirsch M; Masalha W; Franco P; Grauvogel J; Capper D; Schrimpf D; Urbach H; Weyerbrock A
J Neuropathol Exp Neurol; 2016 Apr; 75(4):358-65. PubMed ID: 26921879
[TBL] [Abstract][Full Text] [Related]
13. Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas.
Broniscer A; Chamdine O; Hwang S; Lin T; Pounds S; Onar-Thomas A; Shurtleff S; Allen S; Gajjar A; Northcott P; Orr BA
Acta Neuropathol; 2016 Feb; 131(2):299-307. PubMed ID: 26744350
[TBL] [Abstract][Full Text] [Related]
14. Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.
Lehman NL; Hattab EM; Mobley BC; Usubalieva A; Schniederjan MJ; McLendon RE; Paulus W; Rushing EJ; Georgescu MM; Couce M; Dulai MS; Cohen ML; Pierson CR; Raisanen JM; Martin SE; Lehman TD; Lipp ES; Bonnin JM; Al-Abbadi MA; Kenworthy K; Zhao K; Mohamed N; Zhang G; Zhao W
Neuro Oncol; 2017 Jan; 19(1):31-42. PubMed ID: 27416954
[TBL] [Abstract][Full Text] [Related]
15. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C
Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
[TBL] [Abstract][Full Text] [Related]
16. Genomic Analysis of Dysembryoplastic Neuroepithelial Tumor Spectrum Reveals a Diversity of Molecular Alterations Dysregulating the MAPK and PI3K/mTOR Pathways.
Surrey LF; Jain P; Zhang B; Straka J; Zhao X; Harding BN; Resnick AC; Storm PB; Buccoliero AM; Genitori L; Li MM; Waanders AJ; Santi M
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1100-1111. PubMed ID: 31617914
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
[TBL] [Abstract][Full Text] [Related]
18. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
19. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization.
Weber RG; Sabel M; Reifenberger J; Sommer C; Oberstrass J; Reifenberger G; Kiessling M; Cremer T
Oncogene; 1996 Sep; 13(5):983-94. PubMed ID: 8806688
[TBL] [Abstract][Full Text] [Related]
20. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ
Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]